A detailed history of Personal Capital Advisors Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Personal Capital Advisors Corp holds 160,483 shares of CRL stock, worth $29.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
160,483
Previous 177,226 9.45%
Holding current value
$29.8 Million
Previous $34.9 Million 0.22%
% of portfolio
0.17%
Previous 0.19%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $3.3 Million - $4.19 Million
-16,743 Reduced 9.45%
160,483 $35 Million
Q3 2022

Nov 07, 2022

BUY
$182.44 - $250.54 $2.31 Million - $3.17 Million
12,654 Added 7.69%
177,226 $34.9 Million
Q2 2022

Aug 04, 2022

BUY
$204.13 - $302.4 $2.54 Million - $3.76 Million
12,446 Added 8.18%
164,572 $35.2 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $2.75 Million - $3.89 Million
10,756 Added 7.61%
152,126 $43.2 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $215,044 - $274,592
-612 Reduced 0.43%
141,370 $53.4 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $27.4 Million - $33.7 Million
-73,597 Reduced 34.14%
141,982 $58.6 Million
Q2 2021

Aug 11, 2021

SELL
$294.17 - $371.65 $70,306 - $88,824
-239 Reduced 0.11%
215,579 $79.7 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $20,472 - $24,557
82 Added 0.04%
215,818 $62.6 Million
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $661,560 - $752,807
-2,980 Reduced 1.36%
215,736 $53.9 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $813,193 - $1.05 Million
-4,632 Reduced 2.07%
218,716 $49.5 Million
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $236,610 - $377,732
-1,991 Reduced 0.88%
223,348 $38.9 Million
Q1 2020

May 12, 2020

BUY
$98.9 - $178.34 $102,262 - $184,403
1,034 Added 0.46%
225,339 $28.5 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $11.9 Million - $14.5 Million
94,680 Added 73.04%
224,305 $34.3 Million
Q3 2019

Nov 07, 2019

BUY
$125.07 - $143.67 $544,054 - $624,964
4,350 Added 3.47%
129,625 $17.2 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $1.69 Million - $2.03 Million
-13,687 Reduced 9.85%
125,275 $17.8 Million
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $381,230 - $533,657
3,637 Added 2.69%
138,962 $20.2 Million
Q4 2018

Jan 16, 2019

BUY
$105.09 - $137.23 $84,912 - $110,881
808 Added 0.6%
135,325 $15.3 Million
Q3 2018

Oct 09, 2018

BUY
$112.11 - $134.54 $250,902 - $301,100
2,238 Added 1.69%
134,517 $18.1 Million
Q2 2018

Aug 01, 2018

BUY
$102.37 - $117.25 $238,010 - $272,606
2,325 Added 1.79%
132,279 $14.9 Million
Q1 2018

May 09, 2018

BUY
$98.19 - $115.2 $456,387 - $535,449
4,648 Added 3.71%
129,954 $13.9 Million
Q4 2017

Jan 19, 2018

BUY
$100.43 - $118.09 $471,920 - $554,904
4,699 Added 3.9%
125,306 $13.7 Million
Q3 2017

Oct 23, 2017

BUY
$96.72 - $109.26 $11.7 Million - $13.2 Million
120,607
120,607 $13 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Personal Capital Advisors Corp Portfolio

Follow Personal Capital Advisors Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.